Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Why Moderna Stock Slumped Today
04:49pm, Tuesday, 06'th Sep 2022
New vaccine guidelines by U.S. health authorities may dampen sales of the biotech's top coronavirus vaccine.
Why Novavax Stock Sank to a New 52-Week Low Today
04:35pm, Tuesday, 06'th Sep 2022 The Motley Fool
The vaccine maker's recent regulatory victories aren't landing with investors.
3 Robinhood Stocks to Buy Right Now
02:16pm, Tuesday, 06'th Sep 2022 The Motley Fool
These stocks are bargains today -- and set to deliver growth tomorrow.
Shifting Covid Vaccine Coverage to Private Payers Is Good for Moderna, Pfizer
12:54pm, Tuesday, 06'th Sep 2022
It looks like there will be plenty of Covid vaccines available for a fall and winter surge, but once the money in the current program runs out, the U.S. government won't be paying for them.
The All-Weather ETF Portfolio For Retirement
04:03am, Tuesday, 06'th Sep 2022 Seeking Alpha
A successful retirement can be attained by following some very simple suggestions. Click here for our all-weather ETF portfolio for retirement.
Novavax's (NVAX) COVID-19 Jab Gets Approval in Switzerland
05:08pm, Monday, 05'th Sep 2022 Zacks Investment Research
Novavax (NVAX) receives expanded temporary authorization for Nuvaxovid, its COVID-19 vaccine, in Switzerland for adolescents aged 12 to 17 and as a booster in adults aged 18 years and above.
Moderna: Patient Investors Are Given Another Fantastic Buy Point On The Pullback
11:42am, Monday, 05'th Sep 2022
MRNA has fallen nearly 30% from its August highs, as it got rejected by the $200 resistance level again. As a result, we urged investors to be cautious in July. Investors need to be wary about Moderna
7 Growth Stocks That Could 10X by 2027
08:43am, Monday, 05'th Sep 2022
MarketWatch published an article early in 2022 which highlighted last year's best-performing S&P 500, mid-cap, small-cap, Nasdaq-100, and Dow 30 stocks. Some of the names on the five lists were cite
2 Top Biotech Stocks to Buy Right Now
10:30am, Sunday, 04'th Sep 2022 The Motley Fool
They have what it takes to generate major revenue over the years to come.
Novavax's (NVAX) COVID-19 Booster Gets CHMP Recommendation
05:45pm, Friday, 02'nd Sep 2022 Zacks Investment Research
The European Medicines Agency's CHMP recommends expanded conditional marketing authorization for Novavax's (NVAX) COVID-19 vaccine as a booster for adults.
Moderna (MRNA) Down 28.4% Since Last Earnings Report: Can It Rebound?
03:31pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Moderna (MRNA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Veeva Systems Stock a Buy Now?
03:15pm, Friday, 02'nd Sep 2022 The Motley Fool
The cloud-based life sciences CRM provider faces a tough slowdown.
PFE, BNTX and MRNA Omicron Boosters Get Positive CHMP Opinion
01:06pm, Friday, 02'nd Sep 2022 Zacks Investment Research
Pfizer (PFE) /BioNTech (BNTX) and Moderna (MRNA) get positive CHMP opinion for Omicron-targeting bivalent booster.
The Zacks Analyst Blog Highlights Pfizer /BioNTec and Moderna's
11:59am, Friday, 02'nd Sep 2022 Zacks Investment Research
Pfizer /BioNTec and Moderna are part of The Zacks top Analyst Blog.
PFE, BNTX and MRNA Omicron Boosters Get Positive CHMP Opinion
10:32am, Friday, 02'nd Sep 2022
Pfizer (PFE) /BioNTech (BNTX) and Moderna (MRNA) get positive CHMP opinion for Omicron-targeting bivalent booster.
